ImmunoGen, Inc.

ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase…

Biotechnology

US, Waltham [HQ]

Competitors · Subsidiaries · Locations

Context Analysis

Competitors · Subsidiaries · Locations

The Contextualizer is eligible to "contextualize" the market relationships of ImmunoGen, Inc.,
e.g. through tracking it's acquisitions, subsidiaries, offices, fabrics and competitors around the globe.

Tip: If you see a dot, it's always worth scrolling up so that the map enlarges and points on top of each other (e.g. NYC vs. Fort Lee) can be differentiated.

U.S. · Business Intelligence

The U.S. map and table tracks offices, fabrics, competitors and subsidiaries located in the United States.

Worldwide · Business Intelligence

The worldwide map and table tracks NON-US offices, fabrics, competitors and subsidiaries.

Worldwide · Competitors Table

Sourced from FMP or manual.

Competitor	Source	Accuracy	Country	City
Reata Pharmaceuticals, Inc.	FMP	High	United States	Plano
Madrigal Pharmaceuticals, Inc.	FMP	High	United States	West Conshohocken
TG Therapeutics, Inc.	FMP	High	United States	New York
Axsome Therapeutics, Inc.	FMP	High	United States	New York
Akero Therapeutics, Inc.	FMP	High	United States	South San Francisco

Worldwide · Subsidiaries Table

Sourced from the SEC, through government awards and manual entries.

Subsidiary	Private?	Country	City
-	-	-	-